当前位置: 首页 > 期刊 > 《医学信息》 > 201420
编号:13682215
坦洛新联合爱普列特治疗良性前列腺增生症的临床观察
http://www.100md.com 2014年5月21日 张昊
第1页

    参见附件。

     摘要:目的探讨坦洛新联合爱普列特治疗良性前列腺增生症的有效性及安全性。方法回顾性分析泌尿科BPH患者218例,其中对照组患者75例,给予坦洛新缓释胶囊;治疗组患者143例在对照组基础上加用爱普列特片,并记录两组患者症状改变情况及不良反应。 结果 3个月后两组患者症状改善明显,治疗组病情改善各项指标均优于对照组两组差异显著具有统计学意义。 结论 单用坦洛新治疗良性前列腺增生症安全有效,坦洛新与爱普列特联合用药可以迅速缓解症状,临床效果将更加明显。

    关键词:坦洛新;爱普列特;良性前列腺增生症

    Epristeride Tamsulosin Combination Treatment of Benign Prostatic Hyperplasia Clinical Observation

    ZHANG Hao

    (Department of Surgery,The Third People's Hospital of Yueyang City, Yueyang 41400,Hunan,China)

    Abstract:Objective To investigate tamsulosin combination treatment of benign prostatic hyperplasia epristeride effectiveness and safety. MethodsA retrospective analysis of 218 cases of patients with BPH urology, including the control group 75 patients given tamsulosin release capsules; patients treated with 143 cases in the control group based on the use epristeride films, and recorded two symptoms changing circumstances and adverse reactions. Results Three months later two groups of patients symptoms improved significantly in the treatment group to improve the condition of the indicators are better than the control group, there were significant difference statistically significant ......

您现在查看是摘要介绍页,详见PDF附件